Expression of glucocorticoid receptor and early growth response gene 1 during postnatal development of two inbred strains of mice exposed to early life stress.
Early life stress can elicit profound changes in adult gene expression and behavior. One consequence of early life stress is a decreased expression of glucocorticoid receptors (GRs) in the frontal cortex and hippocampus. However, neither the time of onset nor the mechanism(s) leading to decreased GR expression during postnatal development are known. The present study used two inbred strains of mice that differ in their behavioral responsiveness to stress (Balb/c and C57Bl/6), exposed them to an established paradigm of early life stress (infant maternal separation), and measured their expression of frontal cortical and hippocampal GRs and the putative transcriptional activator of the GR gene, early growth response gene (egr)-1, at defined stages of postnatal development. In both strains, real-time RT-PCR experiments revealed that decreased expression of GR in adolescence and adulthood is, in fact, preceded by increased GR expression during early life stress exposure. Thus, the early life stress-induced disruption of the normal stress-hyporesponsive period during infancy is accompanied by increased GR expression. Moreover, chronic treatment with the antidepressant drug fluoxetine during adolescence or adulthood reversed the effect of early life stress on adult GR mRNA expression. In contrast to the strain-independent effect of early life stress on GR expression, however, changes in egr-1 expression occurred only in Balb/c mice, and unlike the biphasic developmental changes in GR mRNA expression, egr-1 mRNA was decreased throughout postnatal development. Moreover, there was no consistent overlap of anatomic regions affected by decreased GR and egr-1 protein expression. Thus, in Balb/c mice, changes in GR and egr-1 expression can independently contribute to the phenotypes resulting from early life stress exposure. These findings illustrate that the impact of early life stress on gene expression changes is modulated by the genetic background and that the persistent changes in GR and egr-1 expression that arise early during postnatal developmental are reversible by chronic fluoxetine treatment during adolescence and adulthood.
Navailles
Sylvia
S
Department of Molecular Therapeutics, New York State Psychiatric Institute, New York, N.Y., USA.
Zimnisky
Ross
R
Schmauss
Claudia
C
D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use; D051766:Early Growth Response Protein 1 / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology / Q000627:therapeutic use; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006624:Hippocampus / Q000254:growth & development / Q000378:metabolism*; D008297:Male; D008426:Maternal Deprivation; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D019579:Neocortex / Q000254:growth & development / Q000378:metabolism*; D010641:Phenotype; D011965:Receptors, Glucocorticoid / Q000235:genetics* / Q000378:metabolism; D013315:Stress, Psychological / Q000188:drug therapy / Q000235:genetics*
D018687:Antidepressive Agents, Second-Generation; D051766:Early Growth Response Protein 1; C486109:Egr1 protein, mouse; D011965:Receptors, Glucocorticoid; D005473:Fluoxetine
Mol Endocrinol. 2000 Apr;14(4):506-17
10770488
Neurosci Biobehav Rev. 2007;31(1):3-17
16950513
Endocr Rev. 1998 Jun;19(3):269-301
9626555
Am J Psychiatry. 1993 Nov;150(11):1618-29
8214170
J Neurosci. 2007 Feb 7;27(6):1467-73
17287521
Neurosci Biobehav Rev. 2005;29(8):1335-46
16095695
Ann N Y Acad Sci. 1994 Nov 30;746:275-88; discussion 289-93
7825883
Nat Neurosci. 2005 May;8(5):664-72
15834420
Neuroendocrinology. 1995 Oct;62(4):340-7
8544947
Neuroscience. 2003;119(3):887-97
12809708
Endocrinology. 2009 Jun;150(6):2709-16
19213843
Neuroscience. 2008 Mar 18;152(2):417-28
18280047
Mol Endocrinol. 1990 Oct;4(10):1427-37
1704480
Biol Psychiatry. 2004 Feb 15;55(4):367-75
14960289
J Comp Neurol. 2008 Aug 1;509(4):372-81
18512685
J Neurosci. 2007 Feb 14;27(7):1756-68
17301183
Neuropsychopharmacology. 2004 Jul;29(7):1321-30
15085085
Brain Res Mol Brain Res. 1993 May;18(3):195-200
8497182
Brain Cogn. 2010 Feb;72(1):73-85
19616355
Trends Neurosci. 1999 Apr;22(4):167-73
10203854